Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?

被引：0
|
作者：
Choi, Jonggi [1 ]
Choi, Won-Mook [1 ]
Lim, Young-Suk [1 ]
机构：
[1] Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, 88, Olymp Ro 43-gil, Seoul 05505, South Korea
来源：
CLINICS IN LIVER DISEASE | 2023年 / 27卷 / 04期
关键词：
Lamivudine; Adefovir; Entecavir; Tenofovir; Hepatitis B; Hepatocellular carcinoma; CHRONIC HEPATITIS-B; TENOFOVIR DISOPROXIL FUMARATE; HEPATOCELLULAR-CARCINOMA; DOUBLE-BLIND; ANTIVIRAL THERAPY; VIRUS INFECTION; ENTECAVIR; ALAFENAMIDE; RESISTANCE; PHASE-3;
D O I：
10.1016/j.cld.2023.05.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：809 / 818
页数：10
相关论文
共 50 条
  • [41] EFFECT OF MAFLD ON LIVER CARCINOGENESIS IN HBEAG NEGATIVE PATIENTS WITH UNDETECTABLE HBVDNA UNDER NUCLEOS(T)IDE ANALOGS THERAPY
    Amano, Keisuke
    Kawaguchi, Takumi
    Ide, Tatsuya
    Tsutsumi, Tsubasa
    Sano, Tomoya
    Nakano, Dan
    Arinaga-Hino, Teruko
    HEPATOLOGY, 2022, 76 : S243 - S243
  • [42] Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen loss
    Yan Xue
    Meng Zhang
    Tao Li
    Feng Liu
    Li-Xin Zhang
    Xiao-Ping Fan
    Bao-Hua Yang
    Lei Wang
    World Journal of Gastroenterology, 2021, 27 (14) : 1497 - 1506
  • [43] Postoperative Antiviral Therapy With Nucleos(t)ide Analogs in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma
    Zhong, Jian-Hong
    Ma, Liang
    Li, Le-Qun
    ANNALS OF SURGERY, 2017, 265 (04) : E46 - E47
  • [44] When to stop nucleos(t)ide analogues in chronic hepatitis
    Janssen, H. L. A.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 15 - 15
  • [45] Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
    Zoulim, Fabien
    Locarnini, Stephen
    GASTROENTEROLOGY, 2009, 137 (05) : 1593 - 1608
  • [46] PORTAL HYPERTENSION BUT NOT HCC RISK IS ATTENUATED IN COMPENSATED CIRRHOTICS FOLLOWING 10 YEARS OF TREATMENT WITH NUCLEOS(T)IDE ANALOGS
    Invernizzi, F.
    Lampertico, P.
    Mangia, G.
    Iavarone, M.
    Vigano, M.
    Primignani, M.
    De Franchis, R.
    Colombo, M.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E50 - E50
  • [47] Performance of Serum Hbcrag in Chronic Hepatitis B Patients with 8-Year Nucleos(t)Ide Analogs Therapy
    Wang, Meng-Lan
    Chen, Enqiang
    Liao, Juan
    Wang, Juan
    Tang, Hong
    HEPATOLOGY, 2018, 68 : 330A - 330A
  • [48] Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs
    Tsai, Ming-Chao
    Chen, Chien-Hung
    Hu, Tsung-Hui
    Lu, Sheng-Nan
    Lee, Chuan-Mo
    Wang, Jing-Houng
    Hung, Chao-Hung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (07) : 512 - 521
  • [49] Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy
    Wang, Meng-Lan
    Deng, Rong
    Chen, En-Qiang
    Tao, Chuan-Min
    Liao, Juan
    Zhou, Tao-You
    Wang, Juan
    Tang, Hong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : 301 - 309
  • [50] Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs
    Fengmin Lu
    Jie Wang
    Xiangmei Chen
    Dongping Xu
    Ningshao Xia
    Frontiers of Medicine, 2017, 11 : 502 - 508
12345